Clinical Trials Browser

Completed × irofulven × Genitourinary × Clear all

NCT03643107 2025-01-23

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

Phase 2 Completed

Metastatic Castration-Resistant Prostate Cancer Patients

NCT00124566 2016-01-18

Study of Irofulven in Patients With Hormone-refractory Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00003390 2013-06-21

6-Hydroxymethylacylfulvene in Treating Patients With Metastatic Kidney Cancer

Phase 2 Completed

Carcinoma, Renal Cell, Kidney Neoplasms